Atlas Trials

Safety and Efficacy of Brimonidine Intravitreal Implant in Patients With Geographic Atrophy Due to Age-related Macular Degeneration (AMD)

Clinical trial NCT00658619 · COMPLETED

Trial details

NCT number
NCT00658619
Sponsor
Allergan
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Macular Degeneration
Start date
2008-05-01
Primary completion
2010-06-01
Enrollment
119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.